Navigation Links
ACE Inhibitors Seem to Raise Risk of Breast Cancer Recurrence
Date:4/22/2011

g quicker metastasis and a 30-fold increase in cancer spread, deeper analysis revealed.

But in this animal model, beta blockers managed to block the signals that were recruiting the immune cells, explained Ganz.

That same year, a study of more than 400 women in England and Germany found that women on beta blockers also had a lower likelihood of breast cancer recurrence.

The UCLA researchers decided to delve deeper, working with other scientists on a database of 1,779 women with early-stage breast cancer who had been treated at a large health maintenance organization in northern California and followed for about eight years in a study called Life After Cancer Epidemiology (LACE).

The women in the group who were taking ACE inhibitors had a 56 percent increased risk of a recurrence, although they had no increased risk of death.

The 14 percent of women who were taking propanolol -- the beta blocker considered most likely to have a protective effect -- had a reduced risk of recurrence. Because the number of women in this group was so small, the findings did not reach statistical significance, Ganz said, although "it was going in the right direction in terms of being protective."

The risk associated with taking both drugs together was somewhat in the middle.

The study was funded by the Jonsson Comprehensive Cancer Center Foundation, the Breast Cancer Research Foundation and the U.S. National Cancer Institute.

Noting the need for further studies, Ganz is working with researchers in Denmark and Canada to evaluate the same medications and their relationship to recurrence in much larger samples of breast cancer patients.

"We've always been addressing the treatment of the cancer itself but in this study [they were looking at whether] there is something in the host, in the milieu that makes us more susceptible to the development of a malignancy. Is there something we can actually change?" said Dr. Lauren Cassell, chi
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. ACE inhibitors may increase risk of recurrence in breast cancer survivors
2. Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity
3. Combining 2 peptide inhibitors might block tumor growth
4. Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate
5. JAK inhibitors producing significant response in myelofibrosis patients
6. Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors
7. Birth Even a Few Weeks Early May Raise Odds for ADHD
8. Low Glucose Levels May Raise Death Risk Among Older People
9. NIDA raises the curtain on addiction
10. Having Both Autism and Epilepsy Linked to Raised Death Rates
11. Close-Knit Neighborhoods Raise Chances of Stroke Survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ACE Inhibitors Seem to Raise Risk of Breast Cancer Recurrence
(Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in business. NAPW is the nation’s leading ... 700,000 members and over 200 operating Local Chapters. , ... said NAPW President Star Jones. “Job satisfaction is essential ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Linda Cade as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to recognize Linda with this important honor,” said NAPW ...
(Date:6/1/2015)... June 01, 2015 Carson Energy also ... their investors IRA transactions. AdvantaIRA Trust, LLC is the ... the ability to fund positions using IRA’s does 2 ... on a project, even if there current cash position ... additional funding source for Carson and their investors to ...
(Date:6/1/2015)... The Delta Dental Foundation is currently seeking ... Michigan, Ohio and Indiana for its Brighter Futures Community ... has been set. , Across the tri-state area, the ... specifically focus on children’s oral health and $100,000 in ... adults. Each grant request will be considered and carefully ...
(Date:6/1/2015)... 01, 2015 EBSCO Health , ... introduced DynaMed Plus™ , a cross-platform evidence-based clinical ... It provides clinicians with the ideal blend of evidence ... paths. , DynaMed Plus is a significant enhancement ... the most frequently updated evidence-based content. DynaMed Plus content ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
... University of California, San Diego, have identified a key ... in humans and mice. This groundbreaking discovery has implications ... of patients with pulmonary arterial hypertension and prevent the ... this debilitating disease. In a paper to be ...
... today,s Scientific Program of the 2009 American Academy of ... Meeting include: John T. Flynn, MD, Columbia University School ... in caring for the vision of the tiniest premature ... Stanford University School of Medicine, on barriers to glaucoma ...
... ... Advantage has developed a proprietary web application named “iCompli®” designed to ... their physician protocols. The application is designed to notify the ... their mobile phone. iCompli® will work with any mobile device or ...
... patients have best chance at some visual recovery, research suggests ... improve the vision of people with a severe form of ... new study shows. , People with LCA, which is caused ... vision loss and abnormal eye movements in early infancy and ...
... ... Debate , ... (Vocus) October 22, 2009 -- According to the Centers for Disease Control and Prevention, the ... country. They also report that hospitalizations of related cases have been above average for this ...
... "Physician ... of EMR Adoption , , ... Doylestown, PA (PRWEB) October 23, 2009 -- myemrchoice.com announced that they will ... Doctors EMR Quarterly and the EMR Power Ranking. The new EMR planning resources ...
Cached Medicine News:Health News:UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 2Health News:Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic 2Health News:Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic 3Health News:Bariatric Advantage Launches First of Its Kind Mobile Vitamin Reminder Web Application 2Health News:Gene Therapy Offers Hope for Severe Hereditary Eye Disease 2Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 2Health News:Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 3Health News:MyEMRchoice.com develops EMR Power Rankings for Selection of Electronic Medical Records 2
(Date:6/2/2015)... June 2, 2015 ... mejora  de 7,9 meses en la supervivencia libre ... con cáncer colorrectal metastático inoperable (mCRC) tratados  en ... Y-90 más quimioterapia    Los beneficios ... directamente al hígado con la quimioterapia sistémica actual ...
(Date:6/1/2015)... June 2, 2015 Amgen (NASDAQ: ... on a Phase 1b study to evaluate the ... oncolytic immunotherapy, in combination with Roche,s investigational anti-PDL1 ... with triple-negative breast cancer and colorectal cancer with ... investigational oncolytic immunotherapy designed to selectively replicate in ...
(Date:6/1/2015)... , June 1, 2015   Regulus Therapeutics ... company leading the discovery and development of innovative ... G. Xanthopoulos , Ph.D. has resigned as President ... of Regulus, Board of Directors, effective today, to ... Grint, M.D., who previously served as Chief Medical ...
Breaking Medicine Technology:Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... a basic Peripheral Nerve Locator only, which ... location during regional anesthesia. Ideal for day ... constant current NS232, NS252, NS272 PNS are ... programmed. ,Hand-held, battery operated, and includes automatically ...
Pocket-size digital nerve locator optimizes ease and convenience of performing peripheral nerve blocks. Includes RBW-5L electrode lead set, 9V alkaline battery, and durable molded polyethylene carryi...
Single cuff electronic tourniquet....
The Lone Star Retractor System may be adapted to a specific region of the anatomy by simply adjusting the hinges. The system also includes multiple ring shapes, slots on perifephery of retractor ring...
Medicine Products: